THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COMMON STOCK
Total 13F shares
98,585,434
Share change
-1,826,528
Total reported value
$707,886,177
Put/Call ratio
203%
Price per share
$7.18
Number of holders
114
Value change
-$36,188,565
Number of buys
65
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q3 2015

As of 30 Sep 2015, THERAVANCE INC - COMMON STOCK (THRX) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,585,434 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BlackRock Fund Advisors, STATE STREET CORP, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, Empyrean Capital Partners, LP, Litespeed Management, L.L.C., and PERRY CORP. This page lists 114 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.